These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16103190)

  • 1. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.
    Balsitis S; Dick F; Lee D; Farrell L; Hyde RK; Griep AE; Dyson N; Lambert PF
    J Virol; 2005 Sep; 79(17):11392-402. PubMed ID: 16103190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
    Song S; Gulliver GA; Lambert PF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
    Slebos RJ; Lee MH; Plunkett BS; Kessis TD; Williams BO; Jacks T; Hedrick L; Kastan MB; Cho KR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5320-4. PubMed ID: 8202487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
    Balsitis S; Dick F; Dyson N; Lambert PF
    Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.
    Balsitis SJ; Sage J; Duensing S; Münger K; Jacks T; Lambert PF
    Mol Cell Biol; 2003 Dec; 23(24):9094-103. PubMed ID: 14645521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
    Shin MK; Balsitis S; Brake T; Lambert PF
    Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF).
    Seavey SE; Holubar M; Saucedo LJ; Perry ME
    J Virol; 1999 Sep; 73(9):7590-8. PubMed ID: 10438849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
    Gulliver GA; Herber RL; Liem A; Lambert PF
    J Virol; 1997 Aug; 71(8):5905-14. PubMed ID: 9223480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway.
    Jones DL; Thompson DA; Suh-Bürgmann E; Grace M; Münger K
    Virology; 1999 Jun; 258(2):406-14. PubMed ID: 10366578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.
    Melillo RM; Helin K; Lowy DR; Schiller JT
    Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
    Pan H; Griep AE
    Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
    Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
    Park JW; Shin MK; Lambert PF
    Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.